| scholarly article | Q13442814 |
| P2093 | author name string | Rodolfo García-Contreras | |
| Paula Licona-Limón | |||
| María Guadalupe García-Patiño | |||
| P2860 | cites work | MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 | Q22009943 |
| Structure and signalling in the IL-17 receptor family | Q24648045 | ||
| LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells | Q24675869 | ||
| Acinetobacter baumannii: an emerging opportunistic pathogen | Q26830893 | ||
| TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review | Q28066798 | ||
| Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product | Q28141458 | ||
| Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE | Q28276828 | ||
| Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection | Q28478751 | ||
| Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components | Q28511151 | ||
| Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America | Q29616084 | ||
| Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach | Q31162617 | ||
| Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response | Q33552294 | ||
| Vaccines for Acinetobacter baumannii: thinking "out of the box". | Q33637895 | ||
| Progress and Challenges in Implementing the Research on ESKAPE Pathogens | Q45710828 | ||
| Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. | Q51818859 | ||
| Essential role of toll-like receptor 4 in Acinetobacter baumannii-induced immune responses in immune cells. | Q53361231 | ||
| Purification and characterization of a major 40 kDa outer membrane protein of Acinetobacter baumannii. | Q54106492 | ||
| Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. | Q55033421 | ||
| Differential Roles of CD14 and Toll-like Receptors 4and 2 in MurineAcinetobacterPneumonia | Q62516238 | ||
| C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme | Q67956577 | ||
| Analysis of hospital bacteriological data | Q69917081 | ||
| Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals | Q76388506 | ||
| Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells | Q80271299 | ||
| High susceptibility to respiratory Acinetobacter baumannii infection in A/J mice is associated with a delay in early pulmonary recruitment of neutrophils | Q84159892 | ||
| The human antimicrobial peptide LL-37 and its fragments possess both antimicrobial and antibiofilm activities against multidrug-resistant Acinetobacter baumannii | Q86045411 | ||
| Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii | Q86642757 | ||
| Toll‑like receptor 2 promotes bacterial clearance during the initial stage of pulmonary infection with Acinetobacter baumannii | Q87354453 | ||
| Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. | Q33642529 | ||
| Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections | Q33767602 | ||
| Complement control protein factor H: the good, the bad, and the inadequate. | Q34067107 | ||
| Role of fibronectin in the adhesion of Acinetobacter baumannii to host cells | Q34238383 | ||
| Role of macrophages in early host resistance to respiratory Acinetobacter baumannii infection | Q34328536 | ||
| A comparative review of toll-like receptor 4 expression and functionality in different animal species | Q34431296 | ||
| Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity | Q34557992 | ||
| Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. | Q34574281 | ||
| Epithelial innate immune response to Acinetobacter baumannii challenge | Q34596026 | ||
| Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem | Q35132306 | ||
| Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance | Q35139329 | ||
| Host fate is rapidly determined by innate effector-microbial interactions during Acinetobacter baumannii bacteremia | Q35661920 | ||
| Neutropenia exacerbates infection by Acinetobacter baumannii clinical isolates in a murine wound model | Q36167957 | ||
| Current advances and challenges in the development of Acinetobacter vaccines | Q36256352 | ||
| Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice | Q36314004 | ||
| Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes | Q36569183 | ||
| Lipopolysaccharide-deficient Acinetobacter baumannii shows altered signaling through host Toll-like receptors and increased susceptibility to the host antimicrobial peptide LL-37. | Q36646684 | ||
| Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase | Q36778860 | ||
| A Study of the Moraxella Group II. Oxidative-negative Species (Genus Acinetobacter ) | Q36848285 | ||
| Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice | Q37099423 | ||
| Acinetobacter baumannii phenylacetic acid metabolism influences infection outcome through a direct effect on neutrophil chemotaxis. | Q37213637 | ||
| The roles of IL-17A in inflammatory immune responses and host defense against pathogens | Q37374929 | ||
| Social networking of human neutrophils within the immune system | Q38219743 | ||
| The Nod1, Nod2, and Rip2 axis contributes to host immune defense against intracellular Acinetobacter baumannii infection | Q38328275 | ||
| High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia | Q38470424 | ||
| Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins | Q38491423 | ||
| Interleukin-17 and innate immunity in infections and chronic inflammation | Q38496581 | ||
| Neutrophil extracellular trap cell death requires both autophagy and superoxide generation | Q38706817 | ||
| A novel bacterial transport mechanism of Acinetobacter baumannii via activated human neutrophils through interleukin-8. | Q40629390 | ||
| Bacterial isolates in neutropenic febrile patients | Q40752257 | ||
| CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein | Q40866140 | ||
| Acinetobacter baumannii escape from neutrophil extracellular traps (NETs). | Q41714198 | ||
| Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. | Q41762392 | ||
| Diabetic murine models for Acinetobacter baumannii infection | Q43237805 | ||
| Some immunological properties of lipopolysaccharide from Acinetobacter baumannii | Q43790242 | ||
| NK1.1(+) cells regulate neutrophil migration in mice with Acinetobacter baumannii pneumonia | Q44294907 | ||
| Serine protease PKF of Acinetobacter baumannii results in serum resistance and suppression of biofilm formation | Q44572234 | ||
| Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program | Q45027537 | ||
| Taxonomy of the Genus Acinetobacter with the Recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and Emended Descriptions of Acinetobacter calcoac... | Q45310974 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | hospital-acquired infection | Q215509 |
| Acinetobacter baumannii | Q3241189 | ||
| emerging pathogen | Q108429945 | ||
| P304 | page(s) | 441 | |
| P577 | publication date | 2017-04-12 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections | |
| P478 | volume | 8 |
| Q89582639 | A Cyclic-di-GMP signalling network regulates biofilm formation and surface associated motility of Acinetobacter baumannii 17978 |
| Q64091015 | Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice |
| Q64963647 | Aging exacerbates mortality of Acinetobacter baumannii pneumonia and reduces the efficacies of antibiotics and vaccine. |
| Q92372451 | Antibacterial Activities of Aliphatic Polyester Nanocomposites with Silver Nanoparticles and/or Graphene Oxide Sheets |
| Q90458207 | Biological sex influences susceptibility to Acinetobacter baumannii pneumonia in mice |
| Q90732878 | Carbapenem-Resistant Acinetobacter baumannii in Three Tertiary Care Hospitals in Mexico: Virulence Profiles, Innate Immune Response and Clonal Dissemination |
| Q38650814 | Caspase-11 Plays a Protective Role in Pulmonary Acinetobacter baumannii Infection. |
| Q90369616 | Comparison of Cefepime/Cefpirome and Carbapenem Therapy for Acinetobacter Bloodstream Infection: A Multicentre Study |
| Q97521500 | Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy |
| Q93197815 | Genomic and Phenotypic Analyses of Acinetobacter baumannii Isolates From Three Tertiary Care Hospitals in Thailand |
| Q92404410 | Human Pleural Fluid Elicits Pyruvate and Phenylalanine Metabolism in Acinetobacter baumannii to Enhance Cytotoxicity and Immune Evasion |
| Q89965762 | Hybrid Antigens Expressing Surface Loops of ZnuD From Acinetobacter baumannii Is Capable of Inducing Protection Against Infection |
| Q90235208 | Innate Immune Responses to Acinetobacter baumannii in the Airway |
| Q94561407 | Lipopolysaccharide-Deficient Acinetobacter baumannii Due to Colistin Resistance Is Killed by Neutrophil-Produced Lysozyme |
| Q98202475 | Mechanisms Protecting Acinetobacter baumannii against Multiple Stresses Triggered by the Host Immune Response, Antibiotics and Outside-Host Environment |
| Q94593104 | Nosocomial Infection Agents of Şişli Hamidiye Etfal Training and Research Hospital: Comparison of 1995 and 2017 Data |
| Q50185124 | Pathogenic Bacterium Acinetobacter baumannii Inhibits the Formation of Neutrophil Extracellular Traps by Suppressing Neutrophil Adhesion |
| Q92576300 | Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection |
| Q92971747 | Study of the immunogenicity of outer membrane protein A (ompA) gene from Acinetobacter baumannii as DNA vaccine candidate in vivo |
| Q92404420 | The Mechanisms of Disease Caused by Acinetobacter baumannii |
| Q89824042 | Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response |
Search more.